Acridine carboxamide
Term · Oncology and biomedicine · MLC-T-ONC-000174
A substance being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. Also called DACA.
A tricyclic acridine-based (or carboxamide-based) drug with dual topoisomerase inhibitor and potential antineoplastic activities. Acridine carboxamide inhibits both topoisomerases I and II and intercalates into DNA, resulting in DNA damage, the disruption of DNA repair and replication, the inhibition of RNA and protein synthesis, and cell death.
| Identifier | MLC-T-ONC-000174 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | DACA |
| Synonyms | DACA |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-000174",
"term": "Acridine carboxamide",
"field": "Oncology and biomedicine",
"definitions": [
"A substance being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. Also called DACA.",
"A tricyclic acridine-based (or carboxamide-based) drug with dual topoisomerase inhibitor and potential antineoplastic activities. Acridine carboxamide inhibits both topoisomerases I and II and intercalates into DNA, resulting in DNA damage, the disruption of DNA repair and replication, the inhibition of RNA and protein synthesis, and cell death."
],
"abbreviation": "DACA",
"synonyms": [
"DACA"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/acridine-carboxamide/"
}
Record 276 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.